Logo

HTG to Analyze Gene Expression for Takeda Pharmaceutical

Sep 22, 2004

NEW YORK, Sept. 22 (GenomeWeb News) - HTG will provide gene expression analysis services to Takeda Pharmaceutical of Japan, HTG said today.

 

Under the agreement, Tucson, Ariz.-based HTG will use its ArrayPlate technology to analyze samples provided by Takeda, which is based in Osaka.

 

HTG's ArrayPlate contains a Universal Array in each well of a 96-well microplate. The arrays can be programmed using HTG's reagents for the simultaneous measurement of DNA and RNA from the same sample. The assays rely on a quantitative nuclease protection assay.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.